AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

Illumina Inc. (ILMN)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

101.00

0.76 (0.76%)

At close: Feb 18, 2025, 3:59 PM

undefined% (undefined)

Bid	101
Market Cap	16.00B
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	-7.69
PE Ratio (ttm)	-13.13
Forward PE	n/a
Analyst	Buy

Ask	102.5
Volume	2,264,949
Avg. Volume (20D)	2,260,989
Open	100.00
Previous Close	100.24
Day's Range	99.33 - 103.00
52-Week Range	97.36 - 156.66
Beta	undefined

About ILMN

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequenci...

[Show more]

Industry Medical - Diagnostics & Research

Sector Healthcare

IPO Date Jul 28, 2000

Employees 8,970

Stock Exchange NASDAQ

Ticker Symbol ILMN

Website https://www.illumina.com

Full Company Profile

Analyst Forecast

According to 18 analyst ratings, the average rating for ILMN stock is "Buy." The 12-month stock price forecast is $150, which is an increase of 48.51% from the latest price.

Buy 55.56%

Hold 38.89%

Sell 5.56%

Stock Forecasts

Next Earnings Release

Illumina Inc. is scheduled to release its earnings on May 1, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

1 week ago

-5.47%

Illumina shares are trading lower after Barclays d... Unlock content with Pro Subscription

1 week ago

-1.51%

Illumina shares are trading lower. The company reported Q4 financial results.

News

1 day ago · zacks.com

NVIDIA's Rise Puts These 3 Healthcare Stocks in the Spotlight

ILMN, IQV and DXCM are leveraging AI advancements to drive innovation in genomics, clinical research and diabetes management.

6 days ago · zacks.com

Here's Why Illumina (ILMN) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 week ago · zacks.com

ILMN vs. ALNY: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Biomedical and Genetics stocks have likely encountered both Illumina (ILMN) and Alnylam Pharmaceuticals (ALNY). But which of these two stocks offers value inves...

1 week ago · zacks.com

Why Illumina (ILMN) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 week ago · fool.com

Why Illumina Stock Got Mashed on Monday

On Monday, for the second time in as many business days, Illumina (ILMN -5.47%) stock took it on the chin because of an analyst recommendation downgrade. The biotech's shares closed the day almost 6% ...

1 week ago · zacks.com

Illumina (ILMN) International Revenue Performance Explored

Review Illumina's (ILMN) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.

1 week ago · seekingalpha.com

Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability

Illumina restored its profitability well: Free Cash Flow is reaching elevated levels. However, the placement of ILMN in China's unreliable entity list could have disruptive implications for its operat...

1 week ago · 247wallst.com

Cathie Wood Sours on Tesla and Moderna, but Likes These Stocks Instead

Star portfolio manager Cathie Wood's Ark Investment Management filed its 13F holdings report for the fourth quarter on Feb.

1 week ago · fool.com

Why Illumina Stock Is Sinking Today

Shares of Illumina (ILMN -8.97%) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m.

1 week ago · benzinga.com

Illumina Analysts Slash Their Forecasts Following Q4 Results

Illumina, Inc. ILMN reported better-than-expected results for its fourth quarter on Thursday.

Load More News